A comprehensive study by the University of California links cannabis use to an increased risk of serious cardiovascular events, with higher usage correlating to greater risk, underscoring the need for awareness and caution among users.
Japan approves Daiichi Sankyo-AstraZeneca’s Enhertu
The latest approval is based on data from the Phase II DESTINY-Lung02 trial of Enhertu for treating unresectable advanced or recurrent non-small cell lung cancer.